EN
HI
CORONA Remedies Chart
CORONA Remedies Share Key Metrics
Volume
9756.00
Market Cap
10400.27 CR
LTQ@LTP
5@1700.50
ATP
1702.3
Var Margin
12.72 %
Circuit Range
1342.7-2013.9
Delivery %
37.49 %
Value
1.66 CR
ASM/GSM
No
Market Lot
1
Summary
CORONA Remedies share price is ₹1700.5 as of 2 Jun, 2026. The stock CORONA Remedies intraday movement has stayed between ₹1684.50 and ₹1718.10, while on a 52-week basis,CORONA Remedies price 52 week high is ₹1949.40 & its 52 week low is ₹1336.60.
In terms of trading activity, CORONA Remedies has recorded a volume of 9756 shares, The CORONA Remedies has a market cap of ₹61160088 CR. The stock’s Average Traded Price (ATP) stands at ₹1702.30, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5 @ ₹1700.50.
CORONA Remedies operates within a circuit range of ₹1342.70 – ₹2013.90, with a Value of ₹1.66 CR. The Delivery Percentage for the day is 37.49%. Additionally, CORONA Remedies currently falls under the No framework, and trades with a market lot size of 1.
CORONA Remedies Fundamentals
View MoreP/E Ratio
55.32
P/B Ratio
13.71
Div. Yield
0.6
Sector P/E
69.53
Sector P/B
2.99
Sec. Div. Yield
0.55
CORONA Remedies Resistance and Support
Pivot 1709.73
Resistance
First Resistance
1754.46
Second Resistance
1830.63
Third Resistance
1875.36
Support
First Support
1633.56
Second Support
1588.83
Third Support
1512.66
CORONA Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-11 | Audited Results & Final Dividend |
| 2026-02-02 | Quarterly Results |
| 2026-01-02 | Quarterly Results |
CORONA Remedies News
CORONA Remedies Limited
Corona Remedies received EU-GMP Compliance Certification for its hormone manufacturing facility and renewed EU-GMP for its Oral Solid Dosage (OSD) manufacturing facility in Ahmedabad, strengthening global manufacturing capabilities and market access.
May 28 2026 15:37:36
Corona Remedies Ltd - 544644 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corona Remedies Ltd received EU-GMP compliance certification for its Hormone manufacturing facility and renewed EU-GMP approval for its Oral Solid Dosage (OSD) facility in Bhayla, Ahmedabad. This strengthens the company's global manufacturing capabilities and supports market expansion.
May 28 2026 15:34:38
Read More
CORONA Remedies Management
| Name | Position |
|---|---|
| Kirtikumar Laxmidas Mehta | Chairman |
| Niravkumar Kirtikumar Mehta | Managing Director & Chief Executive Officer |
CORONA Remedies Similar Stocks
Metropolis Healthcare Ltd.
541.50
0.65 (0.12%)
Sanofi Consumer Healthcare India Ltd.
4670.90
84.20 (1.84%)
Viyash Scientific Ltd.
249.95
-0.45 (0.18%)
Marksans Pharma Ltd.
241.19
2.51 (1.05%)
Concord Biotech Ltd.
1166.20
104.90 (9.88%)
Strides Pharma Science Ltd.
1075.00
-19.10 (1.75%)
Shilpa Medicare Ltd.
517.35
18.10 (3.63%)
Healthcare Global Enterprises Ltd.
631.65
-14.50 (2.24%)
Jupiter Life Line Hospitals Ltd.
1314.60
9.30 (0.71%)
Procter & Gamble Health Ltd.
6030.50
-32.50 (0.54%)
CORONA Remedies FAQs
The Buying Price of CORONA Remedies share is 1700.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy CORONA Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for CORONA Remedies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of CORONA Remedies shares is 55.32. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio CORONA Remedies shares is 13.71. Useful to assess the stock's value relative to its book value.
To assess CORONA Remedies’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of CORONA Remedies is 10400.27 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of CORONA Remedies share price is 1949.40 & 1336.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
CORONA Remedies belongs to the Healthcare sector.
